Financhill
Back

Praxis Precision Medicines, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53

PRAX
Praxis Precision Medicines, Inc.

Last Price:
$268.96
Seasonality Move:
-11.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Praxis Precision Medicines, Inc. Stock Forecast

  • Over the next 52 weeks, Praxis Precision Medicines, Inc. has on average historically risen by 68.3% based on the past 5 years of stock performance.
  • Praxis Precision Medicines, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Praxis Precision Medicines, Inc. Stock Undervalued?
    The current Praxis Precision Medicines, Inc. [PRAX] share price is $268.95. The Score for PRAX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • PRAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Praxis Precision Medicines, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Praxis Precision Medicines, Inc. has on average historically risen by 68.3% based on the past 5 years of stock performance.

Praxis Precision Medicines, Inc. Stock Rating

Buy
53
Praxis Precision Medicines, Inc. (PRAX) is a Buy

Is Praxis Precision Medicines, Inc. overpriced?

  • Praxis Precision Medicines, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Praxis Precision Medicines, Inc. Stock Price History

Is PRAX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRAX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
praxismedicines.com

52-Week Data

52-Week High:
286.50
52-Week Low:
26.70

Prediction Charts

Market Cap:
6.7B
Price in USD:
268.95
Volume:
251.5K
Beta:
2.83

Technical Analysis

SMA50:
208.64
SMA100:
128.16
SMA200:
84.89
52-Wk Change:
243.84%

Stock Predictions

  • Is Praxis Precision Medicines, Inc. stock public?
    Yes, Praxis Precision Medicines, Inc. is a publicly traded company.
  • What is the Praxis Precision Medicines, Inc. stock quote today?
    The Praxis Precision Medicines, Inc. stock price is 268.95 USD today.
  • How to buy Praxis Precision Medicines, Inc. stock online?
    You can buy Praxis Precision Medicines, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-8 256.92 270.98 278.00 256.71
Dec-9 271.00 258.13 278.44 256.50
Dec-10 255.71 261.58 265.00 251.00
Dec-11 261.40 267.28 271.69 252.20
Dec-12 263.98 268.80 274.35 263.84
Dec-15 272.46 276.40 282.99 270.55
Dec-16 270.98 274.51 282.00 269.77
Dec-17 270.72 265.86 276.50 263.53
Dec-18 270.31 269.26 275.31 262.31
Dec-19 271.65 272.92 279.14 267.51
Dec-22 273.00 280.40 285.85 268.57
Dec-23 277.91 275.73 286.50 274.07
Dec-24 279.48 274.76 279.48 270.01
Dec-26 271.03 268.95 273.88 266.51

Praxis Precision Medicines, Inc. Earnings

Praxis Precision Medicines, Inc. Earnings Report: Per Share Praxis Precision Medicines, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Praxis Precision Medicines, Inc. Forecast Revenue Growth

Praxis Precision Medicines, Inc. Stock Analysis: Historical quarterly revenues per share for Praxis Precision Medicines, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.01 per share, and an increase next year of $0.47 per share.

* Praxis Precision Medicines, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.